Joseph S. Zakrzewski - 10 Apr 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
Issuer symbol
ANTX
Transactions as of
10 Apr 2025
Net transactions value
$0
Form type
4
Filing time
11 Apr 2025, 17:08:46 UTC
Previous filing
23 Dec 2024
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +10,523 +7.8% $0.000000 145,538 10 Apr 2025 Direct F1
holding ANTX Common Stock 405,880 10 Apr 2025 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
F2 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.